Price $0.18 |
Market Cap
69M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
5.21
|
P/S
-
|
Dividend %
-
|
|
P/CF
127.3
|
P/FCF
-
|
Op. Cash Flow
-800
|
FCF
0.0
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-107.30%
|
ROI
-
|
|
ROA
-59.50%
|
EPS Growth
42.60%
|
Current Ratio
0.1
|
Debt/Equity
31.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bimi International Medical Inc (BIMI) | $1.19 | - | - | 6.4M | Strong Buy |
| Evogene Ltd (EVGN) | $0.66 | - | - | 22.7M | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $2.84 | - | - | 14.8M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $24.12 | - | - | 1.19B | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.42 | - | - | 4.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
